Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$197.2M
+72.2% from 2023
Prescriptions
8,072
$24,428.52 per claim
Patients
1,314
1,302 prescribers
Total spending, 2024
$197.2M
$150,066.19 per patient
Medicare prescription drug plans paid $197.2M for Scemblix in 2024, for 8,072 prescriptions and refills to 1,314 patients (up 72.2% from 2023). The average cost per claim was $24,428.52.
California had the highest Medicare cost for Scemblix in 2024: $22.7M for 909 claims, followed by New York ($16.4M).
Neil P Shah, hematology-oncology in Los Angeles, CA, had the highest Medicare cost for Scemblix in 2024: 121 claims costing $2.1M.
Scemblix is made by Novartis AG (NVS), listed in the Medicare spending data as Novartis.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Neil P Shah Los Angeles, CA | Hematology-Oncology | 121 | 16 | $2.1M |
| Krista Tucker Boston, MA | Nurse Practitioner | 30 | Under 11 | $2.0M |
| Srinivas K Tantravahi |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 433 | 2,158 | 415 | $52.5M |
| 2023 | 711 | 4,397 | 704 | $114.5M |
| 2024 | 1,302 | 8,072 | 1,314 | $197.2M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology |
| 44 |
| Under 11 |
| $1.6M |
| Marisa J Hine New York, NY | Nurse Practitioner | 74 | 11 | $1.5M |
| Jorge E Cortes Birmingham, AL | Hematology-Oncology | 17 | Under 11 | $1.5M |
| Peter J Hurley Saint Paul, MN | Hematology-Oncology | 14 | Under 11 | $1.4M |
| James H Essell Cincinnati, OH | Hematopoietic Cell Transplantation and Cellular Therapy | 13 | Under 11 | $1.3M |
| Saji Eapen Knoxville, TN | Hematology-Oncology | 12 | Under 11 | $1.3M |
| Jacqueline L Galdos Washington, DC | Nurse Practitioner | 29 | Under 11 | $1.3M |
| Muhammad Saad Hamid Memphis, TN | Hematology-Oncology | 11 | Under 11 | $1.2M |
| Adewale A Fawole The Villages, FL | Hematology-Oncology | 11 | Under 11 | $1.2M |
| Abdulraheem Yacoub Westwood, KS | Hematology-Oncology | 23 | Under 11 | $1.2M |
| Michael J Mauro New York, NY | Hematology | 54 | Under 11 | $1.1M |
| Derek A Helton Vista, CA | Hematology-Oncology | 12 | Under 11 | $1.1M |
| Laura Milligan Charleston, SC | Nurse Practitioner | 14 | Under 11 | $1.0M |
| Sai Ravi Kiran Pingali Houston, TX | Hematology | 13 | Under 11 | $964K |
| Kristen M Kindervater Ann Arbor, MI | Physician Assistant | 33 | Under 11 | $902K |
| Kathryn E Kennedy Nashville, TN | Nurse Practitioner | 17 | Under 11 | $872K |
| Sumit Gaur El Paso, TX | Hematology-Oncology | 11 | Under 11 | $869K |
| Elizabeth D Weiland Charleston, SC | Nurse Practitioner | 38 | Under 11 | $860K |
| Alice S Mims Columbus, OH | Undefined Physician type | 43 | Under 11 | $837K |
| Sarah J Jimenez Augusta, GA | Nurse Practitioner | 20 | Under 11 | $782K |
| Joshua F Zeidner Chapel Hill, NC | Hematology-Oncology | 36 | Under 11 | $747K |
| Aji Mathew Houston, TX | Nurse Practitioner | 36 | Under 11 | $734K |
| Edna I Flores La Jolla, CA | Hematology-Oncology | 11 | Under 11 | $722K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Novartis NVS | 8,072 | $197.2M |